ESSA Pharma Inc. (EPIX) has an overall financial health rating of C+ with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2025-10-08.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-10-08 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-10-07 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-10-06 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-10-03 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-10-02 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-10-01 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-09-30 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-09-29 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-09-26 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-09-25 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-09-24 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-09-23 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
